Chambal Fertilisers and Chemicals Limited (CHAMBLFERT.NS)
New Delhi, IN
Chambal Fertilisers and Chemicals Limited, alongside its subsidiaries, is involved in the production and sale of fertilizers for agricultural use both in India and internationally. Their extensive product line includes urea, as well as various other farm inputs such as di-ammonium phosphate, muriate of potash, single super phosphate, pesticides, and seeds. The company also supplies insecticides, fungicides, herbicides, NPK fertilizers, specialty plant nutrients, crop protection chemicals, and micro-nutrients, predominantly under its 'Uttam' brand. The organization was founded in 1985 and its main office is located in New Delhi, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +6.51% | +0.28% | -0.48% | -0.33% | -3.63% | -6.19% | -27.26% | +50.15% | +60.29% | +574.50% | +3,668.75% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Agricultural Inputs: +9.5%+24.9% ★ Q1'26: +13.7% (vs Q1'25)
-
EPS growth Agricultural Inputs: +23.0%+18.4% Q1'26: +30.2% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%-2.3% Q1'26: -5.0% (vs Q1'25)
-
EBIT margin Agricultural Inputs: +9.7%+11.2% ★ Q1'26: +5.9% (vs Q1'25)
-
ROIC Agricultural Inputs: +7.4%+17.0% ★ Q1'26: +5.0% (vs Q1'25)
-
Share dilution Agricultural Inputs: +0.0%0.0% ★ Q1'26: -0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×0.40× ★ Q1'26: 1.05× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2010 actual |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
41.27B
est: 42.94B (-3.9%)
|
56.78B
est: 51.99B (+9.2%)
|
75.38B
est: 63.54B (+18.6%)
|
82.02B
est: 85.50B (-4.1%)
|
95.79B
est: 87.83B (+9.1%)
|
95.79B
est: 93.86B (+2.1%)
|
90.08B
est: 103.26B (-12.8%)
|
75.53B
est: 87.66B (-13.8%)
|
75.41B
est: 79.52B (-5.2%)
|
100.95B
est: 83.30B (+21.2%)
|
122.06B
est: 129.35B (-5.6%)
|
127.19B
est: 129.42B (-1.7%)
|
160.69B
est: 153.02B (+5.0%)
|
277.73B
est: 283.08B (-1.9%)
|
179.66B
est: 173.10B (+3.8%)
|
166.46B
est: 166.83B (-0.2%)
|
203.61B
203.61B – 203.61B
+22.0% YoY
|
234.84B
234.84B – 234.84B
+15.3% YoY
|
243.20B
243.20B – 243.20B
+3.6% YoY
|
255.62B
255.62B – 255.62B
+5.1% YoY
|
| EBITDA |
7.41B
est: 4.47B (+65.7%)
|
8.17B
est: 7.24B (+12.9%)
|
8.76B
est: 7.75B (+13.0%)
|
8.15B
est: 9.72B (-16.1%)
|
7.64B
est: 5.98B (+27.8%)
|
7.64B
est: 4.87B (+57.0%)
|
7.63B
est: 6.36B (+20.1%)
|
7.62B
est: 3.37B (+126.0%)
|
8.47B
est: 4.95B (+71.2%)
|
12.54B
est: 7.76B (+61.7%)
|
20.26B
est: 13.36B (+51.6%)
|
24.71B
est: 14.90B (+65.8%)
|
22.69B
est: 15.68B (+44.8%)
|
18.98B
est: 15.90B (+19.4%)
|
20.61B
est: 20.92B (-1.5%)
|
25.16B
est: 20.16B (+24.8%)
|
24.61B
24.61B – 24.61B
+22.0% YoY
|
28.38B
28.38B – 28.38B
+15.3% YoY
|
29.39B
29.39B – 29.39B
+3.6% YoY
|
30.89B
30.89B – 30.89B
+5.1% YoY
|
| EBIT |
4.19B
est: 4.58B (-8.5%)
|
4.71B
est: 4.14B (+13.8%)
|
5.67B
est: 4.46B (+27.2%)
|
5.78B
est: 6.59B (-12.3%)
|
5.76B
est: 4.27B (+34.8%)
|
5.76B
est: 4.47B (+28.9%)
|
6.77B
est: 5.52B (+22.6%)
|
7.01B
est: 5.49B (+27.6%)
|
7.85B
est: 6.14B (+27.8%)
|
11.37B
est: 7.63B (+48.9%)
|
17.45B
est: 14.04B (+24.3%)
|
21.88B
est: 18.64B (+17.4%)
|
19.76B
est: 19.60B (+0.8%)
|
15.96B
est: 19.88B (-19.7%)
|
17.54B
est: 18.07B (-2.9%)
|
21.92B
est: 17.41B (+25.9%)
|
21.25B
21.25B – 21.25B
+22.0% YoY
|
24.51B
24.51B – 24.51B
+15.3% YoY
|
25.38B
25.38B – 25.38B
+3.6% YoY
|
26.68B
26.68B – 26.68B
+5.1% YoY
|
| Net Income |
2.07B
est: 2.24B (-7.3%)
|
2.16B
est: 2.62B (-17.3%)
|
1.29B
est: 3.01B (-57.2%)
|
2.39B
est: 2.13B (+12.0%)
|
2.95B
est: 2.45B (+20.2%)
|
2.95B
est: 2.69B (+9.7%)
|
2.21B
est: 3.11B (-29.0%)
|
3.62B
est: 2.02B (+79.1%)
|
4.99B
est: 3.23B (+54.4%)
|
5.90B
est: 4.90B (+20.4%)
|
12.26B
est: 9.25B (+32.6%)
|
16.55B
est: 12.40B (+33.5%)
|
15.66B
est: 13.04B (+20.1%)
|
10.34B
est: 13.23B (-21.8%)
|
12.76B
est: 13.54B (-5.8%)
|
16.50B
est: 18.05B (-8.6%)
|
20.05B
20.05B – 20.05B
+11.1% YoY
|
21.83B
21.83B – 21.83B
+8.9% YoY
|
22.48B
22.48B – 22.48B
+3.0% YoY
|
21.43B
21.43B – 21.43B
-4.7% YoY
|
| SGA |
12.40B
est: 2.08B (+496.5%)
|
18.41B
est: 2.54B (+625.6%)
|
10.75B
est: 4.70B (+129.0%)
|
11.31B
est: 4.81B (+135.4%)
|
3.79B
est: 3.99B (-5.0%)
|
3.79B
est: 15.70B (-75.9%)
|
1.95B
est: 29.61B (-93.4%)
|
1.83B
est: 20.68B (-91.1%)
|
1.77B
est: 16.64B (-89.3%)
|
1.51B
est: 19.08B (-92.1%)
|
1.80B
est: 1.99B (-9.5%)
|
1.87B
est: 31.70B (-94.1%)
|
1.88B
est: 33.34B (-94.4%)
|
1.99B
est: 33.82B (-94.1%)
|
2.30B
est: 9.14B (-74.9%)
|
2.40B
est: 8.81B (-72.7%)
|
10.76B
10.76B – 10.76B
+22.0% YoY
|
12.41B
12.41B – 12.41B
+15.3% YoY
|
12.85B
12.85B – 12.85B
+3.6% YoY
|
13.50B
13.50B – 13.50B
+5.1% YoY
|
| EPS |
5.22
est: 6.54 (-20.1%)
|
5.78
est: 7.30 (-20.8%)
|
3.80
est: 7.70 (-50.6%)
|
5.73
est: 7.71 (-25.7%)
|
8.12
est: 6.34 (+28.0%)
|
8.12
est: 8.21 (-1.1%)
|
8.20
est: 8.43 (-2.7%)
|
9.21
est: 11.47 (-19.7%)
|
11.90
est: 11.51 (+3.4%)
|
14.51
est: 12.28 (+18.2%)
|
29.49
est: 29.75 (-0.9%)
|
39.76
est: 31.23 (+27.3%)
|
37.62
est: 37.63 (0.0%)
|
24.85
est: 30.98 (-19.8%)
|
30.84
est: 33.81 (-8.8%)
|
41.17
est: 45.07 (-8.6%)
|
50.05
50.05 – 50.05
+11.1% YoY
|
54.50
54.50 – 54.50
+8.9% YoY
|
56.13
56.13 – 56.13
+3.0% YoY
|
53.50
53.50 – 53.50
-4.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-15 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Abhay Baijal | MD & Director | 30M | male |
| Tridib Kumar Barat | Vice President of Legal, Company Secretary & Compliance Officer | 13M | male |
| Anuj Jain | Chief Financial Officer | — | male |
| Ashish Kumar Srivastava | Vice President of Sales & Marketing | — | male |
| Narinder Goyal | Business Head of Manufacturing Operations | — | male |
| Ajay Tayal | Head of Manufacturing | — | male |
| Vijay Sachdeva | Head of Internal Audit & Risk Management | — | male |
| Vinod Mehra | President of Projects | — | male |
| Vishal Mathur | Assistant Vice President of Human Resources & Administration | — | male |
| Vivek Misra | Business Head of TAN & Vice President | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CHAMBLFERT.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
